Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia
Patrick A. Brown(Haemonetics (United States)), Mignon L. Loh(Seattle Children's Hospital), M. Brooke Bernhardt(Baylor College of Medicine), Elad Sharon(National Cancer Institute), Stephen P. Hunger(Children's Hospital of Philadelphia), Gerhard Zugmaier(Amgen (Germany)), Elizabeth A. Raetz(NYU Langone Health), Xinxin Xu(Henan Normal University), Lia Gore(Children's Hospital Colorado), Laura Hogan(Stony Brook Children's Hospital), Meenakshi Devidas(National Institutes of Health), James A. Whitlock(Hospital for Sick Children), Stephanie Terezakis(University of Minnesota), Michael A. Pulsipher(Primary Children's Hospital), Michael J. Borowitz(Johns Hopkins University), Lingyun Ji(University of Southern California)
Cited by 358
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k